Guardian Pharmacy Services, Inc. GRDN
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.49% | 4.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.49% | 4.51% | |||
| Cost of Revenue | 5.20% | 4.39% | |||
| Gross Profit | 6.47% | 4.89% | |||
| SG&A Expenses | -11.30% | 22.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.90% | 7.54% | |||
| Operating Income | 104.91% | -41.36% | |||
| Income Before Tax | -12.81% | 62.86% | |||
| Income Tax Expenses | -10.61% | 61.53% | |||
| Earnings from Continuing Operations | -13.57% | 63.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -76.71% | 0.00% | |||
| Net Income | -14.59% | 64.51% | |||
| EBIT | 104.91% | -41.36% | |||
| EBITDA | 71.84% | -32.78% | |||
| EPS Basic | -14.62% | 64.48% | |||
| Normalized Basic EPS | 20.46% | -0.48% | |||
| EPS Diluted | -14.68% | 64.16% | |||
| Normalized Diluted EPS | 20.34% | -0.72% | |||
| Average Basic Shares Outstanding | 0.03% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||